Dr. David Kessler, who led the FDA and later ran Operation Warp Speed, said obesity rates have jumped from 13% in the 1960s ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

"Slashing health care support for low-income Californians isn't just a budget decision, it is a public health crisis in the ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Eli Lilly & Co.'s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, ...

Opinion: Legal scholar John Shu says a ban or restriction on direct-to-consumer drug advertisements would be illogical and ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...